CAS: 1489389-18-5
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
CCT245737 REF: IN-DA00ABR8CAS: 1489389-18-5 | % | 98.00 €~650.00 € | Tue 07 Jan 25 | |
CCT245737 REF: TM-T7080CAS: 1489389-18-5 | 97.06% - 99.69% | 39.00 €~541.00 € | Mon 13 Jan 25 | |
CCT245737 REF: 3D-PJC38918CAS: 1489389-18-5 | Min. 95% | To inquire | Tue 18 Feb 25 |
Ref: IN-DA00ABR8
5mg | 98.00 € | ||
10mg | 137.00 € | ||
25mg | 192.00 € | ||
50mg | 305.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
CCT245737
CAS:1489389-18-5
CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and …
Formula:
C16H16F3N7O
Purity:
97.06% - 99.69%
Color and Shape:
Solid
Molecular weight:
379.34
Ref: TM-T7080
1mg | 39.00 € | ||
2mg | 51.00 € | ||
5mg | 82.00 € | ||
10mg | 118.00 € | ||
25mg | 220.00 € | ||
50mg | 363.00 € | ||
100mg | 541.00 € | ||
1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
CCT245737
CAS:1489389-18-5
CCT245737 is a novel compound that has shown antitumor activity in colorectal adenocarcinoma cells. The …
Formula:
C16H16F3N7O
Purity:
Min. 95%
Molecular weight:
379.34 g/mol
Ref: 3D-PJC38918
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025